A centerpiece of President Trump’s push to make prescription drugs more affordable is a government website for drug discounts that bears his own name. TrumpRx, launched in February, now has 92 offerings on brand-name prescription drugs made by pharmaceutical companies that announced highly publicized deals with the Trump administration.

But nearly six months since the website launched, those deals on TrumpRx represent less than 12% of the more than 800 brand-name drugs made by participating pharmaceutical companies.

TrumpRx does not offer a wide range of medications, including treatments for inflammatory conditions, HIV and cancer, according to an NPR analysis of a database of drugs on the market maintained by the Food and Drug Administration.

Stay up to date with our Top First newsletter, sent every business day in the morning.

“The key takeaway is that most of these companies are doing this for a small number of products and in a limited setting,” says Dr. Ben Rome, a health policy researcher and physician at Brigham and Women’s Hospital in Boston. “They’re not committing to doing this on a large scale.”

TrumpRx touted as a marketplace for better drug prices

TrumpRx’s origins date back to the Trump Administration’s May 2025 executive order aimed at aligning U.S. drug prices with those paid by other wealthy countries or below them. Last summer, the administration sent letters to 17 pharmaceutical companies with a list of demands.

The lawsuits included selling drugs directly to consumers at lower prices, something some pharmaceutical companies, such as Eli Lilly and Novo Nordisk, had already begun doing.

Drugmakers had 60 days to voluntarily comply with the administration’s demands or, the letters said, “if you refuse to come forward, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices.”

Then came closed-door negotiations, which included the threat of tariffs stemming from an investigation into whether pharmaceutical imports posed a threat to national security.

Although the text of the agreements has not been made public, the administration began announcing the pacts in the fall, starting with Pfizer. It was also when the administration announced it would create TrumpRx, a government website for direct-to-consumer discounts.

TrumpRx launched on February 5 with 43 drugs made by five of those companies.

“I think it’s the most important thing that’s happened in health care in many, many decades,” President Trump said during the launch event at the Eisenhower Executive Office Building, next to the White House. All 17 companies that received letters announced deals with the Trump administration, which they concluded with Regeneron in April.

A limited menu of brand-name medications

As of mid-July, there are 92 brand-name drugs on TrumpRx from 15 of the 17 companies that announced deals with the Trump administration. But those companies make more than 800 brand-name drugs that are on the market today, according to NPR’s analysis of a Food and Drug Administration database of marketed drugs.